{
  "ptid_time": "018_S_2155_2012-12-13",
  "img_path": "/data/qiuhui/data/adni/images/018_S_2155/2012-12-13/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 14,737 mm³, 47.5% below the reference mean. With a Z-score of -1.09 (13.8th percentile), this represents mild atrophy; hippocampal volume measures 7,405 mm³, 4.1% above the reference mean. With a Z-score of 0.37 (64.6th percentile), this represents normal volume ; whole brain volume measures 1,067,530 mm³, 9.5% above the reference mean. With a Z-score of 1.20 (88.5th percentile), this represents mild enlargement; entorhinal cortex volume measures 4,320 mm³, 17.6% above the reference mean. With a Z-score of 1.08 (86.0th percentile), this represents mild enlargement; fusiform gyrus volume measures 20,726 mm³, 21.8% above the reference mean. With a Z-score of 1.99 (97.6th percentile), this represents moderate enlargement; middle temporal gyrus volume measures 21,302 mm³, 11.1% above the reference mean. With a Z-score of 0.97 (83.3th percentile), this represents normal volume . ",
  "text_data": "Age is 70.9 years. Gender is Female. Education: 14 years. MMSE: 28.0. MoCA: 23.0. Logical Memory: 13.0. APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.26 SUVR (mild elevated); Amyloid beta: 719.10 pg/mL (normal ); Total tau: 750.00 pg/mL (profound elevated); Phosphorylated tau: 71.56 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "Reasoning: The patient shows mild ventricular atrophy but otherwise has normal-to-enlarged brain volumes in key regions (hippocampus, entorhinal cortex, fusiform gyrus). Cognitive testing (MMSE 28, MoCA 23) suggests mild impairment, while CSF biomarkers (normal Aβ, elevated T-tau/P-tau) and mild AV45 elevation indicate possible tauopathy or non-AD neurodegeneration.  \nDiagnosis: **MCI**  \nConfidence: **Medium** (atypical biomarker profile with elevated tau but normal Aβ raises uncertainty about underlying pathology)",
  "timestamp": "2025-07-26T00:54:21.959277"
}